Related

SDGs and Paris Agreement force to change the current society to a sustainable, circular and wellness society, as well as the bio-based society across the globe. Based on these circumstances, the Japanese government has developed the “Japan Bioeconomy Strategy” since 2019 to achieve the world’s most advanced bioeconomy society in Japan by 2030. 


The strategy has three featuring points:

  • to promote each market segment in the nine fields with bio-manufacturing, primary production, and healthcare, to achieve 92T yen market size by 2030
  • to create outstanding bio-communities by the end of FY2021 and attract human resources and investment, and enable new products and services
  • to draw up guidelines for data linkage and usage by the end of FY2022, and establish R&D and market introduction platform. 

Industry, academia, and local governments pursue together the strategy and are able to receive various supports from the related Japanese government ministries as needed. The strategy also points out that even if each company or university individually struggles with biological technologies, the real industrialization is unable to be accomplished, and that bio-communities with strong/unique sciences and technologies are absolutely essential in Japan for effective open innovation.

Furthermore, international collaboration is essential to promote bioeconomy, and there is high potential for creating synergies among states sharing fundamental values. Currently, six bio-communities, two global bio-communities and four local bio-communities with unique sciences and technologies, were certified by the Japanese Government Cabinet Office. Companies based in the EU are also invited to get involved and contribute.

Nine market-segments

  1. High functional biomaterials (lightweight properties, durability, safety)
  2.  Bioplastics (alternative general-purpose plastics)
  3. Sustainable primary industry system
  4. Organic (Biological) treatment of wastes and effluent
  5. Healthcare field (lifestyle improvement, functional foods, digital health)
  6. Biologics (e.g. antibodies, regenerative medicines, cell therapy, gene therapy, gene editing)
  7. Biological production system (production applying biological functions)
  8. Analysis, measurement, and experiment systems for biological products
  9. Large timber architecture / Smart forestry

 

Published: April 2023

EU-Japan Centre's News

More
このたび、日本企業の欧州での投資・事業展開に役立つ情報を日本語と英語で月1回お届けするニュースレターを創刊し、第1号(2026年9月号)を公開しました。 近年、日EU関係が幅広く発展し、…
The Minerva Policy Reports deliver comprehensive research on the dynamic political, economic, and…
The Centre quarterly newsletter, June 2026 issue, is now available. In this issue:   Last chance…
The Minerva Policy Reports deliver comprehensive research on the dynamic political, economic, and…
The EU Japan Centre is releasing a weekly press review covering Japan's economic and business…
The EU Japan Centre is releasing a weekly press review covering Japan's economic and business…

Events

More
Japan
16/03/2026 - 19/03/2026
  The next mission will take place from 23-26 March, 2027 Planned application period: September - early November 2026   Please note that this page is still under construction; content relating to…
Online
15/09/2026
The EUIPO and EPO, in cooperation with the EU-Japan Centre, are organising this webinar for Japanese companies. It will introduce practical examples of how companies can protect their brands, designs…
Time in Brussels
-
Time in Tokyo
-
Exchange rate
1€ = 178,632 JPY